ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project
- PMID: 30565275
- DOI: 10.1111/all.13701
ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project
Abstract
Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care.
Keywords: Allergic Rhinitis and its Impact on Asthma; Asthma; Care pathways; Pharmacist; Rhinitis.
© 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Similar articles
-
Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice.Pharmacy (Basel). 2020 May 16;8(2):85. doi: 10.3390/pharmacy8020085. Pharmacy (Basel). 2020. PMID: 32429362 Free PMC article.
-
[Hungarian adaptation and launch of the 2019 ARIA care pathways of allergic rhinitis in Hungary].Orv Hetil. 2020 Dec 6;161(49):2059-2071. doi: 10.1556/650.2020.31919. Print 2020 Dec 6. Orv Hetil. 2020. PMID: 33279881 Hungarian.
-
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.J Allergy Clin Immunol. 2019 Mar;143(3):864-879. doi: 10.1016/j.jaci.2018.08.049. Epub 2018 Sep 29. J Allergy Clin Immunol. 2019. PMID: 30273709 Review.
-
Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022.Clin Transl Allergy. 2022 Oct 5;12(10):e12183. doi: 10.1002/clt2.12183. eCollection 2022 Oct. Clin Transl Allergy. 2022. PMID: 36225265 Free PMC article.
-
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.Clin Transl Allergy. 2019 Sep 9;9:44. doi: 10.1186/s13601-019-0279-2. eCollection 2019. Clin Transl Allergy. 2019. PMID: 31516692 Free PMC article. Review.
Cited by
-
ARIA 2019, Allerjik Rinite Tedavi Yaklaşımı-Türkiye.Turk Thorac J. 2020 Mar 1;21(2):122-133. doi: 10.5152/TurkThoracJ.2019.19084. Print 2020 Mar. Turk Thorac J. 2020. PMID: 32203003 Free PMC article. Review. English.
-
The Potential of Clinical Decision Support Systems for Prevention, Diagnosis, and Monitoring of Allergic Diseases.Front Immunol. 2020 Sep 10;11:2116. doi: 10.3389/fimmu.2020.02116. eCollection 2020. Front Immunol. 2020. PMID: 33013892 Free PMC article. Review.
-
Allergic rhinitis characterization in community pharmacy customers: a cross-sectional study.Int J Clin Pharm. 2021 Feb;43(1):118-127. doi: 10.1007/s11096-020-01115-z. Epub 2020 Sep 20. Int J Clin Pharm. 2021. PMID: 32951180
-
Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice.Pharmacy (Basel). 2020 May 16;8(2):85. doi: 10.3390/pharmacy8020085. Pharmacy (Basel). 2020. PMID: 32429362 Free PMC article.
-
How an Immune-Factor-Based Formulation of Micro-Immunotherapy Could Interfere with the Physiological Processes Involved in the Atopic March.Int J Mol Sci. 2023 Jan 12;24(2):1483. doi: 10.3390/ijms24021483. Int J Mol Sci. 2023. PMID: 36675006 Free PMC article. Review.